Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Distribute MitoSciences' Antibodies and Immunoassays

NEW YORK (GenomeWeb News) – Invitrogen said today that it will become the exclusive North American distributor of all of MitoSciences products, which includes monoclonal antibodies and immunoassays for researching mitochondrial proteins and diseases.
 
Invitrogen said that as MitoSciences’ existing distribution agreements expire, it would take over those agreements worldwide on an exclusive basis. The firms did not disclose how many of those distribution agreements exist.
 
The pact will add more than 200 new products to Invitrogen’s antibody and kit catalog, the Carlsbad, Calif.-based firm said.
 
August Sick, vice president and general manager of Invitrogen’s Cellular Analysis Business Unit, said in a statement that Invitrogen plans to offer prepackaged kits in the future that will combine MitoSciences’ technology with its fluorescent labeling and cell separation technologies for mitochondrial research.
 
The firms did not disclose financial or any other additional terms of the alliance.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.